Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 168

Schmitz, H., Barmeyer, C., Gitter, A.H., et al., 2000. Epithelial barrier and transport function of the
colon in ulcerative colitis. Annu. NY Acad. Sci. 915, 312-326 .
Schrezenmeier, H., Hochsmann, B., 2012. Drugs that inhibit complement. Transfus. Apher. Sci. 46
(1), 87-92 .
Schroder, K., Tschopp, J., 2010. The inlammasomes. Cell 140 (6), 821-832 .
Schuller, S., Frankel, G., Phillips, A.D., 2004. Interaction of Shiga toxin from Escherichia coli with
human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ
culture. Cell Microbiol. 6 (3), 289-301 .
Schuller, S., Heuschkel, R., Torrente, F., et al., 2007. Shiga toxin binding in normal and inlamed
human intestinal mucosa. Microbes Infect. 9 (1), 35-39 .
Selyunin, A.S., Alto, N.M., 2011a. Activation of PAK by a bacterial type III effector EspG reveals
alternative mechanisms of GTPase pathway regulation. Small GTPases 2 (4), 217-221 .
Selyunin, A.S., Sutton, S.E., Weigele, B.A., et al., 2011b. The assembly of a GTPase-kinase
signalling complex by a bacterial catalytic scaffold. Nature 469 (7328), 107-111 .
Sham, H.P., Shames, S.R., Croxen, M.A., et al., 2011. Attaching and effacing bacterial effector
NleC suppresses epithelial inlammatory responses by inhibiting NF-kappaB and p38 mitogen-
activated protein kinase activation. Infect. Immun. 79 (9), 3552-3562 .
Shames, S.R., Bhavsar, A.P., Croxen, M.A., et al., 2011a. The pathogenic Escherichia coli type
III secreted protease NleC degrades the host acetyltransferase p300. Cell Microbiol. 13 (10),
1542-1557 .
Shames, S.R., Croxen, M.A., Deng, W., et al., 2011b. The type III system-secreted effector EspZ
localizes to host mitochondria and interacts with the translocase of inner mitochondrial
membrane 17b. Infect. Immun. 79 (12), 4784-4790 .
Shames, S.R., Deng, W., Guttman, J.A., et al., 2010. The pathogenic E. coli type III effector EspZ
interacts with host CD98 and facilitates host cell prosurvival signalling. Cell Microbiol. 12 (9),
1322-1339 .
Sharma, V.K., Bearson, S.M., Bearson, B.L., 2010. Evaluation of the effects of sdiA, a luxR homologue,
on adherence and motility of Escherichia coli O157: H7. Microbiology 156 (Pt 5), 1303-1312 .
Sharma, V.K., Zuerner, R.L., 2004. Role of hha and ler in transcriptional regulation of the esp
operon of enterohemorrhagic Escherichia coli O157:H7. J. Bacteriol. 186 (21), 7290-7301 .
Shaw, R.K., Berger, C.N., Feys, B., et al., 2008. Enterohemorrhagic Escherichia coli exploits EspA
ilaments for attachment to salad leaves. Appl. Environ. Microbiol. 74 (9), 2908-2914 .
Shaw, R.K., Cleary, J., Murphy, M.S., et al., 2005. Interaction of enteropathogenic Escherichia coli
with human intestinal mucosa: role of effector proteins in brush border remodeling and forma-
tion of attaching and effacing lesions. Infect. Immun. 73 (2), 1243-1251 .
Shiflett, D.E., Clayburgh, D.R., Koutsouris, A., et al., 2005. Enteropathogenic E. coli disrupts tight
junction barrier function and structure in vivo . Lab. Invest. 85 (10), 1308-1324 .
Shringi, S., Garcia, A., Lahmers, K.K., et al., 2012. Differential virulence of clinical and bovine-
biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted
rabbit models. Infect. Immun. 80 (1), 369-380 .
Siegler, R.L., 2003. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome. JAMA 290
(10), 1379-1381 .
Simonovic, I., Rosenberg, J., Koutsouris, A., et al., 2000. Enteropathogenic Escherichia coli
dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell
Microbiol. 2 (4), 305-315 .
Simovitch, M., Sason, H., Cohen, S., et al., 2010. EspM inhibits pedestal formation by entero-
haemorrhagic Escherichia coli and enteropathogenic E. coli and disrupts the architecture of a
polarized epithelial monolayer. Cell Microbiol. 12 (4), 489-505 .